I wrote it was a disgraceful press release at the time, but ppl like cato cannot interpret such data and need the independent experts to guide them a few days after the fact. It was a release for the masses, like any good propaganda campaign. That's what happens when you have credibility and history in curing some of the most difficult to treat viruses ie hepatitis.
MSB has to rely on the science and objective randomized, controlled clinical data. That's OK. That is really the only way for MSCs to go mainstream. That era is fast approaching.
Analysis of the EAP, page-971
-
- There are more pages in this discussion • 100 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.5¢ |
Change
-0.015(1.49%) |
Mkt cap ! $1.136B | |||
| Open | High | Low | Value | Volume |
| $1.02 | $1.02 | 99.5¢ | $2.005M | 1.991M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 14424 | 99.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.00 | 63643 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |